Dalbavancin treatment of prosthetic knee infection due to oxacillin-resistant Staphylococcus epidermidis
Gespeichert in:
| Veröffentlicht in: | Enfermedades infecciosas y microbiologia clinica 2018-02, Vol.36 (2), p.142-143 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng ; spa |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 143 |
|---|---|
| container_issue | 2 |
| container_start_page | 142 |
| container_title | Enfermedades infecciosas y microbiologia clinica |
| container_volume | 36 |
| creator | Ramírez Hidalgo, María Jover-Sáenz, Alfredo García-González, Mercè Barcenilla-Gaite, Fernando |
| description | |
| doi_str_mv | 10.1016/j.eimc.2017.04.009 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1908428489</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1908428489</sourcerecordid><originalsourceid>FETCH-LOGICAL-p126t-17a2d898f6421da4d0ad5c097c7901ab70225ae312d9ab581c48f7785cad0d543</originalsourceid><addsrcrecordid>eNo1kD1PwzAURS0kRCvoH2BAHlkSbDeO7RGVT6kSAzBHL_aLakjsEDuI_nsqUaa7nHt0dQm55KzkjNc3HyX6wZaCcVWyqmTMnJAll0oXXEuxIKuUfMu4qYWSuj4jC6FrdoD5kuzuoG_hG4L1geYJIQ8YMo0dHaeY8g6zt_QzIFIfOrTZx0DdjDRHGn_A-r73oZgw-ZTh0HvNMO72fbTR2jlRHL3DafDOpwty2kGfcHXMc_L-cP-2eSq2L4_Pm9ttMXJR54IrEE4b3dWV4A4qx8BJy4yyyjAOrWJCSMA1F85AKzW3le6U0tKCY05W63Ny_ec97P-aMeVm8Mli30PAOKeGG6YroSttDujVEZ3bAV0zTn6Aad_8v7P-Bfv7aQY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1908428489</pqid></control><display><type>article</type><title>Dalbavancin treatment of prosthetic knee infection due to oxacillin-resistant Staphylococcus epidermidis</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Ramírez Hidalgo, María ; Jover-Sáenz, Alfredo ; García-González, Mercè ; Barcenilla-Gaite, Fernando</creator><creatorcontrib>Ramírez Hidalgo, María ; Jover-Sáenz, Alfredo ; García-González, Mercè ; Barcenilla-Gaite, Fernando</creatorcontrib><identifier>EISSN: 1578-1852</identifier><identifier>EISSN: 2529-993X</identifier><identifier>DOI: 10.1016/j.eimc.2017.04.009</identifier><identifier>PMID: 28600171</identifier><language>eng ; spa</language><publisher>Spain</publisher><subject>Anti-Bacterial Agents - administration & dosage ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Arthroplasty, Replacement, Knee ; Device Removal ; Drug Resistance, Multiple, Bacterial ; Female ; Gentamicins - therapeutic use ; Humans ; Knee Prosthesis - adverse effects ; Middle Aged ; Oxacillin - pharmacology ; Prosthesis-Related Infections - drug therapy ; Prosthesis-Related Infections - microbiology ; Renal Insufficiency, Chronic - complications ; Staphylococcal Infections - drug therapy ; Staphylococcal Infections - etiology ; Staphylococcal Infections - microbiology ; Staphylococcus epidermidis - drug effects ; Staphylococcus epidermidis - isolation & purification ; Teicoplanin - administration & dosage ; Teicoplanin - analogs & derivatives ; Teicoplanin - pharmacology ; Teicoplanin - therapeutic use ; Time Factors ; Vancomycin - therapeutic use</subject><ispartof>Enfermedades infecciosas y microbiologia clinica, 2018-02, Vol.36 (2), p.142-143</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28600171$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ramírez Hidalgo, María</creatorcontrib><creatorcontrib>Jover-Sáenz, Alfredo</creatorcontrib><creatorcontrib>García-González, Mercè</creatorcontrib><creatorcontrib>Barcenilla-Gaite, Fernando</creatorcontrib><title>Dalbavancin treatment of prosthetic knee infection due to oxacillin-resistant Staphylococcus epidermidis</title><title>Enfermedades infecciosas y microbiologia clinica</title><addtitle>Enferm Infecc Microbiol Clin</addtitle><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Arthroplasty, Replacement, Knee</subject><subject>Device Removal</subject><subject>Drug Resistance, Multiple, Bacterial</subject><subject>Female</subject><subject>Gentamicins - therapeutic use</subject><subject>Humans</subject><subject>Knee Prosthesis - adverse effects</subject><subject>Middle Aged</subject><subject>Oxacillin - pharmacology</subject><subject>Prosthesis-Related Infections - drug therapy</subject><subject>Prosthesis-Related Infections - microbiology</subject><subject>Renal Insufficiency, Chronic - complications</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcal Infections - etiology</subject><subject>Staphylococcal Infections - microbiology</subject><subject>Staphylococcus epidermidis - drug effects</subject><subject>Staphylococcus epidermidis - isolation & purification</subject><subject>Teicoplanin - administration & dosage</subject><subject>Teicoplanin - analogs & derivatives</subject><subject>Teicoplanin - pharmacology</subject><subject>Teicoplanin - therapeutic use</subject><subject>Time Factors</subject><subject>Vancomycin - therapeutic use</subject><issn>1578-1852</issn><issn>2529-993X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kD1PwzAURS0kRCvoH2BAHlkSbDeO7RGVT6kSAzBHL_aLakjsEDuI_nsqUaa7nHt0dQm55KzkjNc3HyX6wZaCcVWyqmTMnJAll0oXXEuxIKuUfMu4qYWSuj4jC6FrdoD5kuzuoG_hG4L1geYJIQ8YMo0dHaeY8g6zt_QzIFIfOrTZx0DdjDRHGn_A-r73oZgw-ZTh0HvNMO72fbTR2jlRHL3DafDOpwty2kGfcHXMc_L-cP-2eSq2L4_Pm9ttMXJR54IrEE4b3dWV4A4qx8BJy4yyyjAOrWJCSMA1F85AKzW3le6U0tKCY05W63Ny_ec97P-aMeVm8Mli30PAOKeGG6YroSttDujVEZ3bAV0zTn6Aad_8v7P-Bfv7aQY</recordid><startdate>201802</startdate><enddate>201802</enddate><creator>Ramírez Hidalgo, María</creator><creator>Jover-Sáenz, Alfredo</creator><creator>García-González, Mercè</creator><creator>Barcenilla-Gaite, Fernando</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201802</creationdate><title>Dalbavancin treatment of prosthetic knee infection due to oxacillin-resistant Staphylococcus epidermidis</title><author>Ramírez Hidalgo, María ; Jover-Sáenz, Alfredo ; García-González, Mercè ; Barcenilla-Gaite, Fernando</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p126t-17a2d898f6421da4d0ad5c097c7901ab70225ae312d9ab581c48f7785cad0d543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; spa</language><creationdate>2018</creationdate><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Arthroplasty, Replacement, Knee</topic><topic>Device Removal</topic><topic>Drug Resistance, Multiple, Bacterial</topic><topic>Female</topic><topic>Gentamicins - therapeutic use</topic><topic>Humans</topic><topic>Knee Prosthesis - adverse effects</topic><topic>Middle Aged</topic><topic>Oxacillin - pharmacology</topic><topic>Prosthesis-Related Infections - drug therapy</topic><topic>Prosthesis-Related Infections - microbiology</topic><topic>Renal Insufficiency, Chronic - complications</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcal Infections - etiology</topic><topic>Staphylococcal Infections - microbiology</topic><topic>Staphylococcus epidermidis - drug effects</topic><topic>Staphylococcus epidermidis - isolation & purification</topic><topic>Teicoplanin - administration & dosage</topic><topic>Teicoplanin - analogs & derivatives</topic><topic>Teicoplanin - pharmacology</topic><topic>Teicoplanin - therapeutic use</topic><topic>Time Factors</topic><topic>Vancomycin - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ramírez Hidalgo, María</creatorcontrib><creatorcontrib>Jover-Sáenz, Alfredo</creatorcontrib><creatorcontrib>García-González, Mercè</creatorcontrib><creatorcontrib>Barcenilla-Gaite, Fernando</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Enfermedades infecciosas y microbiologia clinica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ramírez Hidalgo, María</au><au>Jover-Sáenz, Alfredo</au><au>García-González, Mercè</au><au>Barcenilla-Gaite, Fernando</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dalbavancin treatment of prosthetic knee infection due to oxacillin-resistant Staphylococcus epidermidis</atitle><jtitle>Enfermedades infecciosas y microbiologia clinica</jtitle><addtitle>Enferm Infecc Microbiol Clin</addtitle><date>2018-02</date><risdate>2018</risdate><volume>36</volume><issue>2</issue><spage>142</spage><epage>143</epage><pages>142-143</pages><eissn>1578-1852</eissn><eissn>2529-993X</eissn><cop>Spain</cop><pmid>28600171</pmid><doi>10.1016/j.eimc.2017.04.009</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 1578-1852 |
| ispartof | Enfermedades infecciosas y microbiologia clinica, 2018-02, Vol.36 (2), p.142-143 |
| issn | 1578-1852 2529-993X |
| language | eng ; spa |
| recordid | cdi_proquest_miscellaneous_1908428489 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Arthroplasty, Replacement, Knee Device Removal Drug Resistance, Multiple, Bacterial Female Gentamicins - therapeutic use Humans Knee Prosthesis - adverse effects Middle Aged Oxacillin - pharmacology Prosthesis-Related Infections - drug therapy Prosthesis-Related Infections - microbiology Renal Insufficiency, Chronic - complications Staphylococcal Infections - drug therapy Staphylococcal Infections - etiology Staphylococcal Infections - microbiology Staphylococcus epidermidis - drug effects Staphylococcus epidermidis - isolation & purification Teicoplanin - administration & dosage Teicoplanin - analogs & derivatives Teicoplanin - pharmacology Teicoplanin - therapeutic use Time Factors Vancomycin - therapeutic use |
| title | Dalbavancin treatment of prosthetic knee infection due to oxacillin-resistant Staphylococcus epidermidis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T00%3A49%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dalbavancin%20treatment%20of%20prosthetic%20knee%20infection%20due%20to%20oxacillin-resistant%20Staphylococcus%20epidermidis&rft.jtitle=Enfermedades%20infecciosas%20y%20microbiologia%20clinica&rft.au=Ram%C3%ADrez%20Hidalgo,%20Mar%C3%ADa&rft.date=2018-02&rft.volume=36&rft.issue=2&rft.spage=142&rft.epage=143&rft.pages=142-143&rft.eissn=1578-1852&rft_id=info:doi/10.1016/j.eimc.2017.04.009&rft_dat=%3Cproquest_pubme%3E1908428489%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1908428489&rft_id=info:pmid/28600171&rfr_iscdi=true |